http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104211642-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-54 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-052 |
| filingDate | 2014-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104211642-B |
| titleOfInvention | The synthesis and the application in cancer therapy drug of pyrazoline sulphone amide derivative of one class containing tetrahydronaphthalene or chroman skeleton |
| abstract | The synthesis of pyrazoline sulphone amide derivative of one class containing tetrahydronaphthalene or chroman skeleton, it is characterized in that there is below formulaļ¼ The pyrazoline sulphone amide derivative containing tetrahydronaphthalene or chroman skeleton of the present invention is shown quite or better than the inhibitory action of positive control medicine to melanin mouse tumor (B16F10), human breast cancer cell (MCF 7) and cervical cancer cell (HeLa).Therefore the pyrazoline sulphone amide derivative containing tetrahydronaphthalene or chroman skeleton of the present invention can apply to prepare antineoplastic.The invention discloses its preparation method and anti-tumor biological. |
| priorityDate | 2014-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.